Japan started its COVID-19 inoculation campaign in February, but Pfizer Inc's vaccine is still the only one approved in the country.
(Reporting by Ritsuko Ando, editing by Louise Heavens)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.88 USD | +0.66% | +0.84% | +0.31% |
07:00am | US, European nations consider vaccinating workers exposed to bird flu | RE |
05-24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
TOKYO (Reuters) - The chief executive of Japanese pharmaceutical company Shionogi & Co said it may start supplying COVID-19 vaccines later this year, Kyodo News reported on Monday.
Japan started its COVID-19 inoculation campaign in February, but Pfizer Inc's vaccine is still the only one approved in the country.
(Reporting by Ritsuko Ando, editing by Louise Heavens)
1st Jan change | Capi. | |
---|---|---|
+0.31% | 164B | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |